Approval · Notice of Compliance 2058 · 1999
ASMAVENT: Notice of Compliance 2058
Issued January 12, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2058
- Date
- January 12, 1999
- Company
- Technilab Pharma Inc.Mirabel, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Product monograph update - new strengths
- Therapeutic class
- Bronchodilator, beta2-adrenergic stimulant
- Canadian reference product
- VENTOLIN NEBULES P.F. (Glaxo Wellcome Inc.)
Products in this notice
Medicinal ingredients
- SALBUTAMOL SULFATE 0.5 MG per ML
- SALBUTAMOL SULFATE 2 MG per ML